Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Statistics

Total Valuation

ARTV has a market cap or net worth of $64.48 million. The enterprise value is -$63.19 million.

Market Cap	64.48M
Enterprise Value	-63.19M

Important Dates

The next estimated earnings date is Tuesday, November 11, 2025, after market close.

Earnings Date	Nov 11, 2025
Ex-Dividend Date	n/a

Share Statistics

ARTV has 24.43 million shares outstanding. The number of shares has increased by 2,746.19% in one year.

Current Share Class	24.43M
Shares Outstanding	24.43M
Shares Change (YoY)	+2,746.19%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	2.70%
Owned by Institutions (%)	19.43%
Float	5.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.44
P/TBV Ratio	0.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.84, with a Debt / Equity ratio of 0.09.

Current Ratio	13.84
Quick Ratio	13.32
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -86.18% and return on invested capital (ROIC) is -50.15%.

Return on Equity (ROE)	-86.18%
Return on Assets (ROA)	-41.57%
Return on Invested Capital (ROIC)	-50.15%
Return on Capital Employed (ROCE)	-51.43%
Revenue Per Employee	n/a
Profits Per Employee	-$844,180
Employee Count	89
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.25% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-78.25%
50-Day Moving Average	2.82
200-Day Moving Average	4.10
Relative Strength Index (RSI)	49.35
Average Volume (20 Days)	99,760

Short Selling Information

The latest short interest is 305,010, so 1.25% of the outstanding shares have been sold short.

Short Interest	305,010
Short Previous Month	304,476
Short % of Shares Out	1.25%
Short % of Float	5.67%
Short Ratio (days to cover)	4.02

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-81.58M
Pretax Income	n/a
Net Income	-75.13M
EBITDA	-79.07M
EBIT	-81.58M
Earnings Per Share (EPS)	-$3.26

Balance Sheet

The company has $142.37 million in cash and $13.22 million in debt, giving a net cash position of $129.14 million or $5.29 per share.

Cash & Cash Equivalents	142.37M
Total Debt	13.22M
Net Cash	129.14M
Net Cash Per Share	$5.29
Equity (Book Value)	149.04M
Book Value Per Share	6.11
Working Capital	138.30M

Cash Flow

In the last 12 months, operating cash flow was -$69.09 million and capital expenditures -$1.73 million, giving a free cash flow of -$70.81 million.

Operating Cash Flow	-69.09M
Capital Expenditures	-1.73M
Free Cash Flow	-70.81M
FCF Per Share	-$2.90

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARTV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2,746.19%
Shareholder Yield	-2,746.19%
Earnings Yield	-113.92%
FCF Yield	-107.37%

Analyst Forecast

The average price target for ARTV is $17.60, which is 566.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.60
Price Target Difference	566.67%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARTV has an Altman Z-Score of 2.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.37
Piotroski F-Score	2